Bill leads his own consulting firm supporting biotechnology company CEO’s with corporate strategy, fundraising and partnering/licensing transactions. Over the past 19 years, he has helped his clients raise more than $500 million in seed funding, venture capital, IPOs, PIPEs, M&A and licensing deals. His current client roster includes San Diego-based Klotho Therapeutics, Inc. Previously Bill worked for Dupont Merck Pharmaceutical Co. for almost 20 years in roles of increasing responsibility, ultimately as Vice President, Business Development and Marketing Services. Bill holds a Doctor of Philosophy degree in bio-organic chemistry from Oxford University and a B.Sc. in chemistry with First Class Honours from the University of Glasgow.